Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
London
SEC filing record 1 source field available
Fiscal year end
31 December
Mereo BioPharma Group plc has filed 437 SEC EDGAR filings since 01 Dec 2017

SEC filing history

Showing 251-275 of 437 matching filings.

Per page
25
Current page
11
6-K File 001-38452

6-K

Filing date
26 May 2022
Reporting date
26 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
25 May 2022
Reporting date
25 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B/A File 001-38452

8-A12B/A

Filing date
17 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
17 May 2022
Reporting date
17 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
17 May 2022
Reporting date
17 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
09 May 2022
Reporting date
09 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
09 May 2022
Reporting date
09 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
31 Mar 2022
Reporting date
31 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
14 Mar 2022
Reporting date
14 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
01 Mar 2022
Reporting date
01 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91444

SC 13G filing

Filing date
15 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91444

SCHEDULE 13G (AMENDMENT NO. 1)

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91444

SC 13G/A

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91444

SC 13G/A

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91444

SC 13G/A

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91444

MEREO BIOPHARMA GROUP PLC

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91444

AMENDMENT NO. 3 TO SCHEDULE 13G

Filing date
11 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91444

SC 13G/A filing

Filing date
11 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91444

AMENDMENT NO. 1

Filing date
11 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-262151

S-8

Filing date
13 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
22 Dec 2021
Reporting date
22 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91444

SC 13G

Filing date
02 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
30 Nov 2021
Reporting date
30 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
04 Nov 2021
Reporting date
04 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .